MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
162 hedge funds and large institutions have $1.4B invested in Momenta Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 80 increasing their positions, 31 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
40% more call options, than puts
Call options by funds: $4.55M | Put options by funds: $3.24M
13% more funds holding
Funds holding: 143 → 162 (+19)
Holders
162
Holding in Top 10
2
Calls
$4.55M
Puts
$3.24M
Top Buyers
| 1 | +$72.2M | |
| 2 | +$63M | |
| 3 | +$27.2M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$23.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.1M |
Top Sellers
| 1 | -$33.2M | |
| 2 | -$10.6M | |
| 3 | -$9.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.86M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$7.6M |